Enanta Pharmaceuticals Statistics
Total Valuation
ENTA has a market cap or net worth of $164.39 million. The enterprise value is $163.31 million.
Important Dates
The last earnings date was Monday, August 11, 2025, after market close.
Earnings Date | Aug 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ENTA has 21.38 million shares outstanding. The number of shares has increased by 0.79% in one year.
Current Share Class | 21.38M |
Shares Outstanding | 21.38M |
Shares Change (YoY) | +0.79% |
Shares Change (QoQ) | +0.10% |
Owned by Insiders (%) | 6.71% |
Owned by Institutions (%) | 59.62% |
Float | 14.36M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.49 |
Forward PS | 3.38 |
PB Ratio | 2.04 |
P/TBV Ratio | 2.02 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.52 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.00, with a Debt / Equity ratio of 2.61.
Current Ratio | 5.00 |
Quick Ratio | 4.77 |
Debt / Equity | 2.61 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -12.29 |
Financial Efficiency
Return on equity (ROE) is -80.64% and return on invested capital (ROIC) is -18.30%.
Return on Equity (ROE) | -80.64% |
Return on Assets (ROA) | -17.29% |
Return on Invested Capital (ROIC) | -18.30% |
Return on Capital Employed (ROCE) | -37.75% |
Revenue Per Employee | $494,702 |
Profits Per Employee | -$702,382 |
Employee Count | 131 |
Asset Turnover | 0.19 |
Inventory Turnover | n/a |
Taxes
Income Tax | -2.06M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.70% in the last 52 weeks. The beta is 0.88, so ENTA's price volatility has been lower than the market average.
Beta (5Y) | 0.88 |
52-Week Price Change | -38.70% |
50-Day Moving Average | 7.37 |
200-Day Moving Average | 6.91 |
Relative Strength Index (RSI) | 56.42 |
Average Volume (20 Days) | 172,921 |
Short Selling Information
The latest short interest is 2.73 million, so 12.78% of the outstanding shares have been sold short.
Short Interest | 2.73M |
Short Previous Month | 2.46M |
Short % of Shares Out | 12.78% |
Short % of Float | 19.03% |
Short Ratio (days to cover) | 15.18 |
Income Statement
In the last 12 months, ENTA had revenue of $64.81 million and -$92.01 million in losses. Loss per share was -$4.32.
Revenue | 64.81M |
Gross Profit | 64.81M |
Operating Income | -96.82M |
Pretax Income | -118.12M |
Net Income | -92.01M |
EBITDA | -92.73M |
EBIT | -96.82M |
Loss Per Share | -$4.32 |
Full Income Statement Balance Sheet
The company has $204.11 million in cash and $207.10 million in debt, giving a net cash position of -$2.99 million or -$0.14 per share.
Cash & Cash Equivalents | 204.11M |
Total Debt | 207.10M |
Net Cash | -2.99M |
Net Cash Per Share | -$0.14 |
Equity (Book Value) | 79.28M |
Book Value Per Share | 3.71 |
Working Capital | 178.16M |
Full Balance Sheet Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 100.00%, with operating and profit margins of -149.40% and -141.98%.
Gross Margin | 100.00% |
Operating Margin | -149.40% |
Pretax Margin | -145.15% |
Profit Margin | -141.98% |
EBITDA Margin | -143.09% |
EBIT Margin | -149.40% |
FCF Margin | n/a |
Dividends & Yields
ENTA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.79% |
Shareholder Yield | -0.79% |
Earnings Yield | -57.39% |
FCF Yield | n/a |
Analyst Forecast
The average price target for ENTA is $20.75, which is 169.83% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $20.75 |
Price Target Difference | 169.83% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 25.20% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |